Alzheimer's disease

Graphic showing arrows missing the bullseye on a target
Biotech

Alector lays off 17% of staff after ph. 2 Alzheimer's drug fail

Alector's Alzheimer's asset has failed to slow disease progression in a phase 2 study, prompting the company to lay off 41 workers.
Gabrielle Masson Nov 26, 2024 4:50am
brain alzheimers dementia neuroscience gears thought think

Cassava flunks phase 3 Alzheimer's test, stops 2nd trial

Nov 25, 2024 8:45am
Podcast
Top Line

Misconduct and the future of neurodegenerative disease research

Nov 15, 2024 9:06am
success failure signposts

UCB's tau drug flunks Alzheimer's trial days after Roche's exit

Nov 1, 2024 6:01am
blood test tube

Roche collects more data on blood tests for Alzheimer’s disease

Oct 31, 2024 12:32pm
Vertical blocks spelling out TMS sitting next to a brain

Brain stimulation slows Alzheimer's disease in one-year trial

Oct 31, 2024 6:45am